PRWEB

(RTTNews.com) - Pfizer Inc. (PFE) announced enrollment of the first patient in a Phase 2b clinical trial of its investigational Staphylococcus...

Bristol-Myers Squibb CompanyBMY announced that the FDA has cleared its intravenous human programmed death receptor-1 (PD-1) blocking antibody,...

Bristol-Myers Squibb CompanyBMY announced that the FDA has issued a Complete Response Letter (CRL) for its intravenous human programmed death...

Earlier in August, AngioDynamics launched the BioFlo Midline catheter indicated for short-term intravenous therapies ... Analysts' estimates...

and had been taking oral bisphosphonate therapy for two or more years. The women were randomized 1:1 to receive either subcutaneous denosumab...

Pluristem Receives U.S. FDA Clearance to Initiate Clinical Trial of PLX-R18 to Treat Insufficient Hematopoietic Recovery Following Bone Marrow...

The company is also developing an intravenous formulation of neratinib for the treatment of patients with advanced cancer. The company plans to...

(RTTNews.com) - BioLineRx Ltd. (
) has initiated a phase 2b trial for BL-8040 as a novel consolidation treatment for acute myeloid...

Roche RHHBY announced that the FDA has granted approval to the subcutaneous injection of its marketed lymphoma drug MabThera/Rituxan as Rituxan...